Skip to main content

09-29-2021 | EASD 2021 | Conference coverage | News

News in brief

Obstructive sleep apnea risk increased in type 1 diabetes

Author: Eleanor McDermid


medwireNews: People with type 1 diabetes have an increased risk for developing obstructive sleep apnea (OSA), researchers have reported at the virtual 57th EASD Annual Meeting.

The study involved 34,147 UK residents with type 1 diabetes, identified in The Health Improvement Network (THIN) database, who were matched by age, sex, primary care provider, and BMI to 129,500 people who had neither type 1 nor type 2 diabetes.

During follow-up of around 5 years, OSA occurred at a rate of 10.4 cases per 10,000 person–years in people with type 1 diabetes versus 6.1 cases per 10,000 person–years in people without.

This equated to a significant hazard ratio of 1.71 for OSA in people with type 1 diabetes, which changed only minimally, to 1.67, after adjustment for factors including age, sex, smoking status, BMI, and cardiovascular disease.

Presenter Ziyad Alshehri (University of Birmingham, UK) noted that OSA is a well-known complication of type 2 diabetes, but that their study is the first longitudinal analysis to examine the issue in people with type 1 diabetes.

Among these people, the risk for developing OSA was highest in those who were male, older, overweight or obese, had depression or atrial fibrillation, or used lipid-lowering or antihypertensive medications.

Clinicians should therefore be aware of the risk for OSA in patients with this profile, the presenter concluded.

medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group

EASD Annual Meeting; Sept 27–Oct 1, 2021


Novel clinical evidence in continuous glucose monitoring

Novel clinical evidence in continuous glucose monitoring

How real-world studies complement randomized controlled trials

Jean-Pierre Riveline uses data from real-life continuous glucose monitoring studies to illustrate how these can uncover critical information about clinical outcomes that are hard to assess in randomized controlled trials.

This video has been developed through unrestricted educational funding from Abbott Diabetes Care.

Watch the video